What Is Intensity-Modulated Radiation Therapy (IMRT)? (2026 Update)

Intensity-modulated radiation therapy (IMRT) is a radiation technique that independently adjusts beam intensity from multiple directions so the dose conforms even to the concave shape of a tumor. The goal is to deliver the necessary dose to the tumor while sparing the surrounding normal tissue.

Key Summary

• IMRT is a type of external beam radiation therapy delivered by a linear accelerator. It shapes the dose to match the tumor's contour by varying the intensity of beams coming from multiple directions.
• Once treatment ends, no radiation remains in the body, so there is no problem with contact with family members or children afterward (a common feature of external beam radiation therapy).
• In practice, treatment is given five days a week on weekdays. Each visit takes about 15–30 minutes including setup, while the actual beam delivery lasts only a few minutes.
• In prostate cancer, IMRT is used as the standard radiation therapy delivered in fractions over several weeks, while SBRT (stereotactic body radiation therapy) is often discussed as an alternative that greatly reduces the number of sessions.
• For most cancers where particle therapies such as carbon-ion or proton therapy are not suitable, standard radiation therapy including IMRT remains the standard of care.

How Is IMRT Different From SBRT?

• Both techniques concentrate the dose on the tumor's shape to spare normal tissue, but the delivery methods differ.
• IMRT varies the intensity of beams from multiple directions to shape the dose even to a tumor's concave contour, and delivers the total dose in fractions over several weeks. This fractionation exists because cancer cells are less able than normal cells to repair radiation damage; by irradiating once a day over many weeks, normal tissue recovers between sessions while cancer cells accumulate damage they cannot overcome.
• SBRT fixes the target position to within millimeters and delivers a high dose in a small number of sessions. For prostate cancer, when the risk group and prostate size meet certain conditions, SBRT can complete treatment in far fewer sessions.
• Which approach is used is decided in the written opinion based on a comprehensive review of cancer type, stage, location, overall health status, and prior treatment history.

Why Does IMRT Cause Less Damage to Surrounding Normal Tissue?

• The answer lies in adjusting beam 'intensity' to match the tumor's shape. By designing the intensity of each beam coming from different directions differently, the dose can be concentrated at the overlapping point — the tumor — while relatively less dose passes through the surrounding normal tissue along the beam paths.
• The overall direction of advances in radiation therapy technology has been toward 'delivering the necessary dose to the tumor while reducing the amount reaching surrounding tissue,' and IMRT and SBRT are the two representative methods achieving this.
• However, brachytherapy — which places radioactive material directly inside the body (used for cervical cancer, prostate cancer, etc.) — works differently from IMRT and requires separate guidance, such as temporary contact restrictions for a certain period.

What Is the Treatment Sequence?

• External beam radiation therapy, including IMRT, generally proceeds in the following order.
• Step 1, simulation — A CT scan is taken in the same position used during treatment, an immobilization device (a mask for head and neck areas) is made to reproduce the exact same position each time, and position marks are placed on the skin.
• Step 2, dose planning and verification — The radiation oncology department and medical physics team establish and verify the dose plan, which typically takes about one week.
• Step 3, actual treatment — Delivered five days a week on weekdays; each visit takes 15–30 minutes including setup, with the actual delivery lasting only a few minutes. For curative-intent treatment, this is usually divided over several weeks, and the exact number of sessions and total duration are confirmed in the written opinion based on cancer stage and location.
• Step 4, follow-up — Weekly check-ups during treatment monitor the skin and overall condition, and after treatment ends, long-term follow-up continues to check for late-onset side effects.

FAQ — What Side Effects Occur During IMRT?

• There is no sensation at all during the actual beam delivery, and side effects occur only in the area the radiation passed through. Common effects include fatigue and skin changes at the treatment site (redness, dryness, itching, pigmentation). By site, head and neck treatment commonly causes mouth sores, dry mouth, and painful swallowing; chest treatment causes difficulty swallowing and coughing; abdominal and pelvic treatment causes nausea, diarrhea, and urinary discomfort; and breast treatment mainly causes skin reactions.
• Skin changes typically begin around 2 weeks into treatment. Basic care includes gently washing with mild soap, applying a moisturizer recommended by the medical team, and avoiding direct sunlight.
• Most acute reactions appear during treatment and subside within a few weeks after it ends, but late side effects (tissue hardening or functional decline) can appear months to years later, requiring long-term follow-up tailored to the treated site.

FAQ — Can IMRT Be Given Again to an Area That Already Received Radiation Therapy?

• Whether re-irradiation is possible depends on the previously treated site, total dose, and time elapsed. The key records that determine feasibility are the irradiated site, total dose, number of fractions, and treatment dates of the prior radiation therapy. Submitting these records allows the remote review (pre-arrival review) stage to advise on feasibility and alternatives together.
• For overseas patients, records to prepare also include recent CT/MRI scans (original DICOM files), PET-CT, biopsy and pathology reports, and surgical/chemotherapy history.

Sources and Notes

• This article was written based on notes on radiation therapy, skin and fatigue management after radiation therapy, and prostate cancer (sourced from the National Cancer Information Center, NCCN patient guidelines, National Cancer Registration Statistics 2019–2023, the National Cancer Center Korea's Central Cancer Registry, and U.S. National Cancer Institute (NCI) materials).
• This content is intended for general medical information purposes only. Diagnosis, treatment methods, and outcomes may vary depending on individual condition. Please consult your medical team to determine an accurate diagnosis and treatment plan.